Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

Abstract Background The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided by pharmacists in collaboration with physicians improves QOL with outpa...

Full description

Bibliographic Details
Main Authors: Hironori Fujii, Yukino Ueda, Chiemi Hirose, Koichi Ohata, Kumiko Sekiya, Mika Kitahora, Shiori Sadaka, Senri Yamamoto, Daichi Watanabe, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Miho Kaburaki, Nobuhisa Matsuhashi, Takao Takahashi, Akitaka Makiyama, Kazuhiro Yoshida, Hideki Hayashi, Akio Suzuki
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Quality of life
Pharmaceutical intervention
Adverse events related outpatient cancer chemotherapy
EuroQol 5 Dimension5 level (EQ-5D-5L)
Retrospective observational study
Online Access:https://doi.org/10.1186/s40780-022-00239-w

Internet

https://doi.org/10.1186/s40780-022-00239-w

Similar Items